EarningsQ2 2026 Earnings Report
MX:GIVNN Q2 2026 EPS Results
Actual EPS$1133.92
Consensus EPS$1353.87
Beat/MissMissed by -$219.95
One Year Ago EPS$1417.13
MX:GIVNN Q2 2026 Revenue Results
Actual Revenue$84.32B
Expected Revenue$42.66B
Beat/MissBeat by +$41.66B
YoY Revenue Growth-1.68%
Earnings Announcement Details
QuarterQ2 2026
Date07/23/2026
TimeBefore Open
Conference CallThursday, July 23, 2026
MX:GIVNN Upcoming Earnings
Givaudan SA's next earnings date is estimated for January 27, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Neutral
The call conveyed a balanced picture: underlying operational momentum (notably strong performance in Fragrance & Beauty, regional strength in Asia Pacific, sequential improvement in Taste & Wellbeing, and continued innovation and sustainability progress) was offset by significant nonrecurring litigation costs, a negative adjusted free cash flow in H1 driven by higher investments and working capital build, a drop in reported net income and EPS, and higher leverage. Management reaffirmed medium‑term 2030 targets and expects sequential improvement into H2, but near-term cash and litigation risks temper the tone.Company Guidance
Group Sales and Like-for-Like Growth
Group sales H1 2026 were CHF 3,799 million, up 3.6% like-for-like (despite a -1.7% FX impact in CHF), reflecting volume-led, broad-based growth across customer groups and geographies.
Fragrance & Beauty Strong Performance
Fragrance & Beauty sales were CHF 2,010 million, +6.5% like-for-like and +2.9% in CHF. Fine Fragrance grew +7.3% LFL and Consumer Products grew +9.2% LFL, demonstrating strong demand across both global and local customers.
Sequential Recovery in Taste & Wellbeing
Taste & Wellbeing recorded EUR 1,789 million (down -6.3% in CHF but +0.5% LFL) and showed a sequential improvement from -0.4% LFL in Q1 to +1.5% LFL in Q2, indicating early signs of stabilization and the impact of optimization actions.
Adjusted Profitability Remains Industry-Leading
Adjusted EBITDA was CHF 923 million with a margin of 24.3% (adjusted margin vs 25.2% in H1 2025). On a local currency basis adjusted EBITDA rose modestly (+0.8%), showing resilience in operating profitability after adjustments.
Sustainability and Strategic Capabilities Progress
Secured seventh consecutive CDP A for climate action and CDP for supply engagement; opened a new production site in Cikarang, Indonesia; broke ground on fragrance manufacturing expansion in Mexico; acquisition of Eurofragrance contributed ~1.4% to group growth.
Innovation and Commercial Wins
Introduced new application-ready solutions including PRIMALHYAL NeuroYouth and expanded microencapsulation capabilities via strategic investment; launched customer-facing initiatives such as House of Lime and 'Haus of Suds' to accelerate co-creation and product differentiation.
Financial Position and Capital Allocation Discipline
Net investments increased (net investments +CHF 207m, 5.4% of sales) as management prioritizes growth and footprint expansion while reiterating 2030 targets of 4–6% LFL growth and >12% adjusted free cash flow margin over the 2026–2030 cycle.
Regional Strengths
Asia Pacific delivered strong performance with +9.2% like-for-like growth, and EAME contributed +3.0% LFL; North America grew +2.3% LFL at group level driven by Fragrance & Beauty momentum.
MX:GIVNN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed